South Dakota Investment Council cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 25.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 380,617 shares of the healthcare conglomerate’s stock after selling 128,130 shares during the period. UnitedHealth Group accounts for approximately 1.5% of South Dakota Investment Council’s portfolio, making the stock its 8th largest holding. South Dakota Investment Council’s holdings in UnitedHealth Group were worth $70,574,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Mizuho Securities USA Inc. increased its position in shares of UnitedHealth Group by 32.4% in the first quarter. Mizuho Securities USA Inc. now owns 12,500 shares of the healthcare conglomerate’s stock worth $2,121,000 after purchasing an additional 3,061 shares during the last quarter. Ardevora Asset Management LLP increased its position in shares of UnitedHealth Group by 4.7% in the first quarter. Ardevora Asset Management LLP now owns 200,035 shares of the healthcare conglomerate’s stock worth $32,808,000 after purchasing an additional 8,900 shares during the last quarter. FormulaFolio Investments LLC bought a new position in shares of UnitedHealth Group in the first quarter worth approximately $239,000. Parkwood LLC bought a new position in shares of UnitedHealth Group in the first quarter worth approximately $2,141,000. Finally, Bell Bank increased its position in shares of UnitedHealth Group by 4.4% in the first quarter. Bell Bank now owns 2,392 shares of the healthcare conglomerate’s stock worth $392,000 after purchasing an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 86.00% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Incorporated (UNH) Stake Decreased by South Dakota Investment Council” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and republished in violation of United States & international copyright and trademark laws. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/11/14/unitedhealth-group-incorporated-unh-stake-decreased-by-south-dakota-investment-council.html.

In related news, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now directly owns 24,630 shares in the company, valued at approximately $5,060,726.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The disclosure for this sale can be found here. Insiders have sold 72,149 shares of company stock valued at $14,212,342 over the last 90 days. Corporate insiders own 0.89% of the company’s stock.

UnitedHealth Group Incorporated (UNH) opened at $212.66 on Tuesday. UnitedHealth Group Incorporated has a twelve month low of $147.04 and a twelve month high of $213.93. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $204,541.08, a price-to-earnings ratio of 21.99, a PEG ratio of 1.57 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same period last year, the company earned $2.17 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. sell-side analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, November 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.41%. UnitedHealth Group’s payout ratio is presently 33.26%.

Several research analysts recently weighed in on the stock. Credit Suisse Group assumed coverage on shares of UnitedHealth Group in a research report on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 price objective on the stock. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, November 2nd. Mizuho reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, October 24th. Argus increased their price target on shares of UnitedHealth Group from $215.00 to $230.00 and gave the company a “buy” rating in a research report on Thursday, October 19th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $219.00 price target (up from $210.00) on shares of UnitedHealth Group in a research report on Thursday, October 19th. Three investment analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $216.65.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.